Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Treasury Shares (2020 - 2025)

Historic Treasury Shares for Abeona Therapeutics (ABEO) over the last 4 years, with Q3 2014 value amounting to $4000.0.

  • Abeona Therapeutics' Treasury Shares changed 0.0% to $4000.0 in Q3 2014 from the same period last year, while for Sep 2014 it was $4000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $4000.0 for FY2013, which is 0.0% changed from last year.
  • Per Abeona Therapeutics' latest filing, its Treasury Shares stood at $4.1 million for Q3 2025, which was up 2500.32% from $4.9 million recorded in Q2 2025.
  • Abeona Therapeutics' Treasury Shares' 5-year high stood at $5.3 million during Q1 2025, with a 5-year trough of $61108.0 in Q2 2022.
  • Its 5-year average for Treasury Shares is $2.3 million, with a median of $2.4 million in 2023.
  • Over the last 5 years, Abeona Therapeutics' Treasury Shares had its largest YoY gain of 0.0% in 2012, and its largest YoY loss of 0.0% in 2012.
  • Over the past 4 years, Abeona Therapeutics' Treasury Shares (Quarter) stood at $4000.0 in 2011, then changed by 0.0% to $4000.0 in 2012, then changed by 0.0% to $4000.0 in 2013, then changed by 0.0% to $4000.0 in 2014.
  • Its last three reported values are $4000.0 in Q3 2014, $4000.0 for Q2 2014, and $4000.0 during Q1 2014.